About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | AXOS and Microbial Metabolites in CKD

AXOS and Microbial Metabolites in CKD

NCT02141815·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Universitaire Ziekenhuizen KU Leuven

Age

18–85

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age ≥ 18 and ≤ 85 years
Chronic kidney disease stage 3b-4, i.e., with estimated glomerular filtration rate (CKD-epi) between 45 - 15 ml/min/m² 29
Written informed consent

You may not be if

History of organic gastro-intestinal disease (e.g., inflammatory bowel disease, malignancy)
History of colonic surgery
Recipient of a renal or other solid organ transplant
Use of pre-/pro-/syn- or antibiotics in preceding 4 weeks

The record

StatusCompleted

PhaseNo phase

Taking part40

StartedMay 2014

UpdatedApr 27, 2020

Conditions

Chronic Kidney Disease

Where1

University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium